Shahzad Malik, Director, 10% Owner at Conatus Pharmaceuticals Inc (CNAT), bought 2,167,371 shares at $11.00 ($2.3M) on 2013-07-30, disclosed to the SEC on 2013-08-01.
Open-market purchase of $2.3M CNAT by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,888,091 | $0 | 0.0% |
| 2 | $0.08 | 70,003 | $6K | 0.2% |
| 3 | $11.00 | 19,223 | $211K | 9.2% |
| 4 | $11.00 | 190,054 | $2.1M | 90.6% |
| Total | $1.06 avg | 2,167,371 | $2.3M | 100% |
| Filing → |
| VSAR | SELL | 2017-03-15 | $5.5M | — | Filing → |
| AGEN | SELL | 2015-04-30 | $7.9M | — | Filing → |
| VSAR | BUY | 2015-01-26 | $949K | — | Filing → |